Drug Discovery in Preclinical Research

In the drug development, presymptomatic development, additionally named presymptomatic studies and non-clinical studies, is a stage of investigation that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative difficult and drug safety data is collected. Preclinical; in the epidemiological triangle can also be defined as "pre-symptomatic stage" which is known to be, "not yet clinical obvious". 

    Related Conference of Drug Discovery in Preclinical Research

    June 08-09, 2018

    7th International conference on Pharmaceutical Auditing

    Baltimore, Maryland, USA
    June 27-28, 2018

    4th International Conference on Drug Discovery, Designing and Development

    Vancouver, British Columbia, Canada
    August 20-21, 2018

    9th Asian Biologics and Biosimilars Congress

    Tokyo, Japan

    3rd International Conference on Generics Drugs and Biosimilars

    November 15-17, 2018 | Frankfurt, Germany
    October 18-19, 2018

    18th World Pharma Congress

    Warsaw, Poland
    August 15-17, 2018

    8th World Congress Spectroscopy and Analytical Techniques

    Stockholm, Sweden
    September 18-19, 2018

    6th European Biopharma Congress

    Amsterdam, Netherlands

    Drug Discovery in Preclinical Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in